Fortekor plus
| Species | Dogs. | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Composition |
Each tablet contains: - FORTEKOR PLUS 1.25 mg/2.5 mg tablets: 1.25 mg pimobendan, 2.5 mg benazepril hydrochloride Excipients: |
||||||||||||||||||||||||||||||||||||||
| Indications | For the treatment of congestive heart failure due to atrioventricular valve insufficiency or dilated cardiomyopathy in dogs. FORTEKOR PLUS is a fixed dose combination and should only be used in patients whose clinical signs are successfully controlled by administration of the same doses of the individual components (pimobendan and benazepril hydrochloride) given concurrently. | ||||||||||||||||||||||||||||||||||||||
| Dosage and method of administration |
Oral use.
|
||||||||||||||||||||||||||||||||||||||
| Contraindications | Do not use in cases of cardiac output failure due to aortic or pulmonary stenosis. Do not use in cases of hypotension (low blood pressure), hypovolemia (low blood volume), hyponatremia (low blood sodium levels) or acute renal (kidney) failure. Do not use in pregnant or lactating dogs. Do not use in cases of hypersensitivity to pimobendan, to benazepril hydrochloride or to any ingredient of the tablets. |
||||||||||||||||||||||||||||||||||||||
| Waiting period |
Zero days. |
||||||||||||||||||||||||||||||||||||||
| Release form | FORTEKOR PLUS 1.25 mg/2.5 mg tablets: Cardboard box containing 30 tablets Cardboard box containing 60 tablets FORTEKOR PLUS 5 mg/10 mg tablets: Cardboard box containing 30 tablets Cardboard box containing 60 tablets Not all pack sizes may be marketed. |
||||||||||||||||||||||||||||||||||||||
| Storage conditions | Store in a dark place, separate from food and feed, at T°C 5°C + 25°C, in places inaccessible to children. | ||||||||||||||||||||||||||||||||||||||
| Shelf life |
18 months from the date of production. |
||||||||||||||||||||||||||||||||||||||
